Human gut Actinobacteria boost drug absorption by secreting P-glycoprotein ATPase inhibitors
Authors:
Open Access
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Natural Sciences and Engineering Research Council of Canada
- Burroughs Wellcome Fund
- Damon Runyon Cancer Research Foundation (DRR-42-16)
- National Institutes of Health (R01AR074500)
- National Institutes of Health (R01AT011117)
- National Institutes of Health (F30CA257378)
- National Institutes of Health (R01HL122593)
- National Institutes of Health (R21CA227232)
- National Institutes of Health (R01DK114034)
- University of California, San Francisco
This publication has 42 references indexed in Scilit:
- Design, construction, and in vivo augmentation of a complex gut microbiomeCell, 2022
- Tiny Gatekeepers: Microbial Control of Host Drug TransportersClinical Pharmacology & Therapeutics, 2022
- Human gut bacterial metabolism drives Th17 activation and colitisCell Host & Microbe, 2021
- Personalized Mapping of Drug Metabolism by the Human Gut MicrobiomeCell, 2020
- A Genomic Toolkit for the Mechanistic Dissection of Intractable Human Gut BacteriaCell Host & Microbe, 2020
- Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction StudiesClinical Pharmacokinetics, 2020
- Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug OutcomesCell Host & Microbe, 2019
- Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoproteinBiochemical Pharmacology, 2016
- Rapid Assembly of DNA via Ligase Cycling Reaction (LCR)2016
- PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell lineCancer Chemotherapy and Pharmacology, 2009